Alzamend Neuro, Inc. (ALZN) stock
ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
$1.02−0.02 (-1.92%)
Close on Nov 19, 2026Market cap $4.92MP/E –Yield –
Alzamend Neuro revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Alzamend Neuro
Alzamend Neuro has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?